Is higher lymphocyte count a potential strategy for preventing chronic kidney disease in patients receiving long-term dasatinib treatment?

Authors: Hirokazu Nakayama, Hiromitsu Iizuka, Toshiaki Kato, Kensuke Usuki

Source: Journal of Pharmaceutical Health Care and Sciences, Vol 9, Iss 1, Pp 1-7 (2023)

Subject Terms: Dasatinib, Chronic kidney disease, Lymphocyte count, Neutrophil–lymphocyte count ratio, Philadelphia chromosome positive acute lymphoblastic leukemia and chronic myeloid leukemia, Therapeutics. Pharmacology, RM1-950, Pharmacy and materia medica, RS1-441

File Description: electronic resource

Relation: https://doaj.org/toc/2055-0294

Access URL: https://doaj.org/article/a5f1326852644bdd9d71aae24699f5dd